MENA NUTRACEUTICALS MARKET ANALYSIS

MENA nutraceuticals market is estimated to be valued at US$ 14.93 Bn in 2023 and is expected to exhibit a CAGR of 7.2% during the forecast period (2023-2030).

Analysts’ Views on MENA Nutraceuticals Market:

MENA nutraceuticals market growth is driven by rising chronic illness prevalence such as cancer, diabetes, and others, and increased nutraceutical research and development. For instance in May 2020, according to an article published by the Eastern Mediterranean Health Journal, cancer incidence will increase by 1.8 fold in the Gulf countries such as Bahrain, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, and others from 2002-2030.

Figure 1. MENA Nutraceuticals Market Share (%), By Application, 2023

To learn more about this report, request sample copy

MENA Nutraceuticals Market – Drivers

Growing Research and Development Activities to Develop Novel Nutraceuticals

Growing research and development activities by government, as well as market players in the MENA region to develop novel nutraceuticals is expected to drive the MENA nutraceuticals market growth over the forecast period. According to an article published by the North African Journal of Food and Nutrition Research, in July 2021, a research was conducted in December 202o in Algeria, in collaboration with the of University of Béjaia, Chadli Bendjedid University of El-Tarf, Bejaia University, and Royal Food Conservatory, Algeria for determining the mineral profile of lentil flour. The results of this study showed that the mineral content of raw and roasted lentil flour was dramatically increased by the addition of yogurt. Such revelations can be used to develop potential dietary supplements made from lentils and to prevent chronic health conditions such as cancer, type 2 diabetes, cardiovascular disease, and others.

Increased Healthcare Spending

Increasing demand for healthcare services in the MENA region due to high prevalence of chronic and non-communicable diseases and introduction of mandatory healthcare coverage and health insurance schemes are expected to drive the market growth. For instance, on May 01, 2023, according to the HSBC Bank Middle East Limited, demand for healthcare services in the Middle East region is increasing leading to several investment opportunities. As a result, the MENA nutraceuticals market is projected to exhibit a compound annual growth rate (CAGR) of 11.7 % to US$ 2, 43, 600 Million in 2023 from US$ 185.5 billion in 2019.

Figure 2. MENA Nutraceuticals Market Value (US$ Billion), By Region, 2023

To learn more about this report, request sample copy

MENA Nutraceuticals Market- Regional Analysis

Among region, Middle East is estimated to hold a dominant position in the MENA nutraceuticals market over the forecast period owing to the increasing chronic diseases such as cancer, diabetes, etc. Middle East is estimated to hold 65.5% of the market share in 2023. MENA nutraceuticals market is expected to witness significant growth in the near future, owing to increasing prevalence of chronic diseases and rising research and development in the nutraceuticals. For instance, in September 2021, according to IDF (International Diabetes Federation Atlas 10th edition report 2021, 1 in 6 adults (73 million) are living with diabetes. The number of adults with diabetes expected to reach 95 million by 2030 and 136 million by 2045 and 796,000 deaths caused by diabetes in 2021.

MENA Nutraceuticals Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems regarding transportation of drugs from one place to another.

However, the COVID-19 pandemic had positive impact on the MENA nutraceuticals market owing to the rise in the various diseases which leads to the rise in precautionary measures and use of nutraceuticals. According to the data published by the Organization for Economic Co-operation and Development (OECD), in November 2020, COVID-19 has posed major challenges to the healthcare infrastructure in the MENA region. In terms of the overall management of the COVID-19 situation, several nations such as Lebanon, Morocco, and Tunisia, have been severely suffered throughout the pandemic period due to less precautionary measures. Furthermore, the OECD claims that countries including Iran, Syria, Iraq, the Palestinian Authority, Yemen, and Libya are suffering from lack of hospital beds and limited COVID-19 testing capabilities. According to the same source, The COVID-19 epidemic had incurred substantial financial costs for the Middle East. Containment measures implemented by governments in Middle Eastern countries resulted in the restriction of economic activities that contribute to the economy such as manufacturing, import/export, tourism. The OECD estimates that the COVID-19 pandemic caused crude oil prices to bottom out, which will cost the MENA region's GDP 42 million US dollars in 2020.

MENA Nutraceuticals Market- Segmentation:

The MENA nutraceuticals market is segmented into product type, application, distribution channel, and region.

Based on Product Type, MENA nutraceuticals market is segmented into Calcium Supplement Tablets and Gummies, Probiotics Supplement Tablets & Capsules, Collagen Peptide Powder Jar or Sachet, Iron in Tablet and Gummies & Syrup, Folic Acid Tablet, Pyridoxine Tablet, Rocket Seed Oil in Soft Gel, Prenatal Vitamin in Tablet and Gummies, Chaste Berry in Powder and Tablet and Capsule, Natural Eggshell Membrane in Capsule, Melatonin in Tablet, Vitamin C in Tablet, Inositol in Tablet, Whey Protein in Powder and Sachet, Biotin in Tablet, Hypericum perforatum Extract in Capsule, Vitamin D3 in Soft Gel Capsule and Gummies, Omega 3 in Soft Gel and Gummies, Omega 3 Plus Multivitamin in Soft Gel, Gummies Natural Eggshell Membrane in Capsule, CBD (CBD Tinctures, Capsules & Soft gels, CBD Gummies, Others), and Others. Out of which, the Vitamin D3 in Soft Gel Capsule and Gummies segment is expected to dominate the MENA nutraceuticals market during the forecast period due to increasing vitamins deficiency.

Based on Application, MENA nutraceuticals market is segmented into Cancer, Diabetes, Heart Disorders, Hypertension, Obesity, and Others. The diabetes segment is expected to dominate the market over the forecast period due to increasing prevalence of diabetes.

Based on Distribution Channel, the MENA nutraceuticals market is segmented into Hospital Pharmacies, Retail Pharmacies, Convenience Store, Hypermarket/ Supermarket and Online Pharmacies. The online pharmacies is expected to dominate over the forecast period due to the expansion of e-commerce channels by facilitating easier access, increased convenience, and providing a platform for the marketing and promotion of nutraceuticals.

Based on Region, the region is segmented into Middle East and North Africa. Out of which, Middle East is expected to dominate the market over the forecast period due to increasing prevalence of chronic diseases and growing research and development in the field of nutraceuticals.

Among all the segmentations, the product type segment has the highest potential due to increasing product launches by the key market players. In July 2021, Kingsley Beverages, an international company established in with regional offices in the Dubai (UAE), launched Dragon Energy Drink  to maximize mental and physical performance. Dragon Energy Drink is affordable with no compromise on quality and provides amazing taste. Dragon Energy comes in a variety of flavors including the original Dragon Red, Sugar-Free, Xtreme Berry, and Xtreme Citrus.

MENA Nutraceuticals Market- Cross Sectional Analysis

Rising incidence of chronic diseases such as cancer, hepatitis B and C, diabetes, etc., in emerging economies is expected to boost demand for nutraceuticals market in Middle East region. For instance, in February 2022, according to an article published by American Society of Clinical Oncology Journal, more than 436 million people in the Middle East and North Africa region have cancer, with men making up 51.8% of those cases and women making up the remaining 48.2% in Saudi Arabia. New cancer cases were 463,675 in total, corresponding to 2.4% of the global incident cases, and males cancers accounted for 47.3% of that number, compared with 52.7% globally.

MENA Nutraceuticals Market: Key Developments

On January 21, 2023, Baidyanath, a part of (Shree Baidyanath Ayurved Bhawan Pvt. Ltd), an Ayurvedic company, announced the launch of the Ayurvedic medicine Libidex thatincreases libido (sexual desire) in women in Africa. This product launch will further help the company in the expansion of its product portfolio and strengthening its geographical presence in Africa.

In February 2022, Kerry Group Plc., an international innovator in taste & nutrition innovation, announced that it had signed two significant biotechnology acquisitions that have expanded its expertise, technology portfolio and manufacturing capabilities. The company announced that it has acquired the leading biotechnology Innovation Company named c-LEcta, and Mexico-based enzyme manufacturer named Enmex.  c-LEcta - A Kerry Company is a biotechnology innovation company that specializes in precision fermentation, optimized bio-processing ,and bio-transformation. Enmex is a well-established enzyme manufacturer that supplies multiple bio-process solutions to food, beverage, and animal nutrition markets. This has helped the company to increase its revenue.

In September 2022, DFE Pharma, a Middle East & Africa-based company in pharma- and nutraceutical excipient solutions, launched its new “Closer to the Formulator” (C2F), a Center of Excellence, in Hyderabad, India. C2F helped pharmaceutical companies to shorten the time from concept to finished commercial product through its expertise in all phases of pharmaceutical development. This has helped the company to showcase its progress.

In July 2021, PepsiCo, a multinational food, snack, and beverage corporation launched MTN Dew Rise Energy in association with NBA Basketball legend- James Bronn and PepsiCo. The following product line offers six varied products. The canned drink has 16Oz in volume and have 180 mg of caffeine, Vitamins A and C, various antioxidants, and fruit juices to ramp the taste. The products is sold across all the PepsiCo retail locations and would cost US$ 2.59 on average. The product was launched to cater to the morning energy and caffeine boost.

MENA Nutraceuticals Market: Key Trends

Increasing Consumer Healthcare Spending

Sales of consumer healthcare items have been growing gradually in the Middle East and Africa area over the past several years, and this trend is anticipated to continue over the forecast period. The Middle East and North Africa have witnesses increase in healthcare spending over the past few years. This is due to greater public awareness of the importance of making healthy lifestyle adjustments. A clear indication that people are becoming more concerned with their welfare and providing their bodies with the right nutrients and substances to eat is the increase in consumer health care products. For instance, according to Worldbank, the health care expenditure of Saudi Arabia increased from US$ 48226.4 million in 2017 to  US$ 55410.68 million in 2021. The majority of consumers in the region prefer immunity-boosting products such as probiotics, herbal supplements, vitamins, and minerals to control several diseases. As disease outbreaks are very common in Africa, people are gradually adopting preventive healthcare measures in terms of dietary supplements.

MENA Nutraceuticals Market: Restraint

High Cost of Nutraceuticals Products

High prices of the nutraceuticals can hamper the market growth over the forecast period. For instance, on February 02, 2023, according to an article published by the Drug Research, the high cost of whey protein that involves the lots of stages of milk filtration so that no unwanted bacteria can enter the protein and can’t hamper the quality of whey protein. Then it is evaporated and spray dried. Nowadays, flavored whey is also available that adds more steps to the whole production process. Many other hidden steps, such as packaging, storing, others help to get safe, healthy, and nutritious whey protein for consumption. Thus, increases the effective cost of the protein. So the use of natural source of protein cane be implemented for the several source of protein.

MENA Nutraceuticals Market - Key Players

Major players operating in the MENA nutraceuticals market include Nestlé, Nutricia, Unilever, Bionova, BASF SE, Abbott, Arkopharma Laboratories, GSK plc., ADM (Archer Daniels Midland Company), DuPont, Kellogg's Company, Arla Foods amba, DSM, Quantum Naturals Ltd., Adcock Ingram, Ascendis Health Limited, iNova Pharmaceuticals, Vital Health Foods, Jamjoom Pharma, Creso Pharma, and ConnOils LLC.

MENA Nutraceuticals Market – Definition

Nutraceuticals are products that are used for both nutrition and medicine. A substance that has physiological benefit or provides protection against chronic disease is referred to as a nutraceutical product. Nutraceuticals can be used to promote health, slow down the ageing process, prevent chronic diseases, extend life, and maintain body's structure and function. The market is expected to gain traction, owing to multiple applications of nutraceuticals in food & beverages and medical industry. Moreover, various factors such as increasing demand for nutraceuticals, and health benefits associated with nutraceuticals are expected to impact the growth of the MENA nutraceuticals market.